PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab with VEGF TKI cabozantinib in metastatic untreated REnal Cell CancEr (Alliance A031704)
Image

Contact
For more information on this presentation, please contact:
Tian Zhang, MD, MHS
Twitter: @TiansterZhang
Email: Tian Zhang